Please Note: This trial is no longer enrolling new participants
A PHASE 3, OPEN LABEL, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 ? ANTI-CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH CHOP (O-CHOP) VERSUS RITUXIMAB IN COMBINATION WITH CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PARTICIPANTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (OLYMPIA-3)
| Protocol No. | CTO-R1979-ONC-2105 | Scope | National |
|---|---|---|---|
| Principal Investigator | Rita Assi | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
